TLSA (Tiziana Life Sciences) ROE % Adjusted to Book Value : -4.93% (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Tiziana Life Sciences ROE % Adjusted to Book Value?

Tiziana Life Sciences's ROE % for the quarter that ended in Jun. 2024 was -251.87%. Tiziana Life Sciences's PB Ratio for the quarter that ended in Jun. 2024 was 51.06. Tiziana Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -4.93%.

Tiziana Life Sciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Tiziana Life Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tiziana Life Sciences ROE % Adjusted to Book Value Chart

Tiziana Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-29.53

-18.98

-16.49

-13.84

Tiziana Life Sciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-9.95	-28.70	-20.48	-18.93	-4.93

Competitive Comparison of Tiziana Life Sciences's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Tiziana Life Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tiziana Life Sciences's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tiziana Life Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Tiziana Life Sciences's ROE % Adjusted to Book Value falls into.

Tiziana Life Sciences ROE % Adjusted to Book Value Calculation

Tiziana Life Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-140.92%	/	10.18
	=	-13.84%

Tiziana Life Sciences's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-251.87%	/	51.06
	=	-4.93%

Tiziana Life Sciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Tiziana Life Sciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Tiziana Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tiziana Life Sciences Ltd (NAS:TLSA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

0RP:Germany

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM 11

Website

https://www.tizianalifesciences.com

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.